NIS-LL | NIS-LL muscle weakness | |||||
---|---|---|---|---|---|---|
Effect | Coefficient | Standard error | p-value | Coefficient | Standard error | p-value |
Baselinea | 0.0096 | 0.0016 | < 0.0001 | 0.0119 | 0.0019 | < 0.0001 |
Treatment groupb | ||||||
P-T during double-blind phase | 0.3249 | 0.0453 | 0.0088c | 0.1905 | 0.0360 | 0.0132c |
T-T during double-blind phase | 0.1558 | 0.0448 | 0.0636 | 0.0356 |